These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection? Azarpira N, Aghdaie MH, Malekpour Z. Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689 [Abstract] [Full Text] [Related]
23. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children. García-Roca P, Vargas YA, Fuentes Y, Hernández AM, Ortiz L, Valverde S, Velásquez-Jones L, Romero-Navarro B, Ramón-Garcia G, Medeiros M. Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031 [Abstract] [Full Text] [Related]
24. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T. Clin Transplant; 2008 May; 22(1):61-7. PubMed ID: 18217907 [Abstract] [Full Text] [Related]
25. Lymphocytic HLA-A mRNA is a reliable indicator of acute rejection in renal transplantation. Zhou SM, Tian J, Sun R, Shi WF, Peng ZG, Zou X. Transplant Proc; 2008 Dec; 40(10):3384-9. PubMed ID: 19100395 [Abstract] [Full Text] [Related]
26. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients. Bandur S, Petrasek J, Hribova P, Novotna E, Brabcova I, Viklicky O. Transplantation; 2008 Nov 15; 86(9):1206-13. PubMed ID: 19005401 [Abstract] [Full Text] [Related]
27. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study. Gutiérrez P, Marrero D, Hernández D, Vivancos S, Pérez-Tamajón L, Rodríguez de Vera JM, Alarcó A, González-Posada JM. Nephrol Dial Transplant; 2007 May 15; 22(5):1451-5. PubMed ID: 17327283 [Abstract] [Full Text] [Related]
30. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes. Banasik M, Boratyńska M, Kościelska-Kasprzak K, Krajewska M, Mazanowska O, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Nowakowska B, Hałoń A, Dawiskiba T, Chudoba P, Klinger M. Transpl Immunol; 2014 Jan 15; 30(1):24-9. PubMed ID: 24184747 [Abstract] [Full Text] [Related]
34. OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection. Wang YL, Fu YX, Zhu ZJ, Wang H, Shen ZY. Chin Med J (Engl); 2012 Nov 15; 125(21):3786-90. PubMed ID: 23106874 [Abstract] [Full Text] [Related]
35. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR, Smith K, Bourge RC, Tallaj JA, Rayburn BK, Benza R, Zorn G, Leon K, Wille K, Deierhoi M, George JF. J Heart Lung Transplant; 2005 Nov 15; 24(11):1828-33. PubMed ID: 16297789 [Abstract] [Full Text] [Related]
36. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation. von Müller L, Schliep C, Storck M, Hampl W, Schmid T, Abendroth D, Mertens T. J Med Virol; 2006 Mar 15; 78(3):394-9. PubMed ID: 16419118 [Abstract] [Full Text] [Related]